Feedback / Questions
lirentelimab (AK002) - Allakos
AK006 - Allakos
https://www.biospace.com/article/releases/allakos-presents-preclinical-data-at-eaaci-hybrid-congress-2023-highlighting-lirentelimab-and-ak006-mechanisms-of-mast-cell-inhibition/
Jun 12, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next